Tralokinumab as an effective alternative after dupilumab treatment failure in moderate-to- severe atopic dermatitis: A real- world study

被引：1
|
作者：
George, Shaina E. [1 ]
Yu, Jiade [2 ]
机构：
[1] CUNY, SCH MED, NEW YORK, NY USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Dept Dermatol, Boston, MA USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2024年 / 91卷 / 06期
关键词：
atopic dermatitis; contact dermatitis; drugs; eczema; immunobiologics;
D O I：
10.1016/j.jaad.2024.08.019
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1228 / 1230
页数：3
相关论文
共 50 条
  • [21] Comprehensive real-world comparisons between baricitinib and dupilumab treatments for moderate severe atopic dermatitis
    Cho, Yung-Tsu
    Lee, Meng-Sui
    Chang, Wen -Yu
    Lu, Yea-Ting
    Chu, Chia -Yu
    Chan, Tom C.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (07): : 1924 - 1927.e1
  • [22] Efficacy of Dupilumab on Different Phenotypes of Adult with Moderate-to-Severe Atopic Dermatitis in Taiwan: A Real-World Study
    Yang, Chin-Yi
    Lai, Po-Ju
    Chen, Chun-Bing
    Chan, Tom C.
    Hui, Rosaline Chung-Yee
    Huang, Yu-Huei
    Tseng, Han-Chi
    Lin, Shang-Hung
    Lu, Chun-Wei
    Lee, Hua-En
    Lin, Jing-Yi
    Chi, Min-Hui
    Tsai, Ming-Feng
    Hwang, Yih-Shiou
    Wang, Chuang-Wei
    Chu, Chia-Yu
    Chung, Wen-Hung
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (20)
  • [23] Real-world experience of dupilumab treatment for atopic dermatitis
    Martinez Mariscal, Jaime
    Cabana-Navia, Raquel
    Martinez-Fernandez, Alicia
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB101 - AB101
  • [24] Psoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in children
    Parker, Jennifer J.
    Sugarman, Jeffrey L.
    Silverberg, Nanette B.
    Gonzalez, Mercedes Elena
    Ramien, Michele L.
    Teng, Joyce M. C.
    Paller, Amy S.
    PEDIATRIC DERMATOLOGY, 2021, 38 (06) : 1500 - 1505
  • [25] A 52 weeks dupilumab treatment for moderate to severe atopic dermatitis in Korea: long-term efficacy and safety in real world
    Dong Hyek Jang
    Seok Jae Heo
    Hyung Don Kook
    Dong Heon Lee
    Hye Jung Jung
    Mi Yeon Park
    Jiyoung Ahn
    Scientific Reports, 11
  • [26] A 52 weeks dupilumab treatment for moderate to severe atopic dermatitis in Korea: long-term efficacy and safety in real world
    Jang, Dong Hyek
    Heo, Seok Jae
    Kook, Hyung Don
    Lee, Dong Heon
    Jung, Hye Jung
    Park, Mi Yeon
    Ahn, Jiyoung
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [27] MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICACY OF TRALOKINUMAB AND DUPILUMAB IN THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS BEYOND WEEK 16
    Torres, Tiago
    Sohrt Petersen, Anne
    Mariela Rosso, Aldana
    Moreira Taveira, Christian
    Manuel Carrascosa, Jose
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 48 - 48
  • [28] Laboratory markers of dupilumab patients with moderate-to-severe atopic dermatitis: a single-center, real-world study
    Hawkins, K.
    Sharma, D.
    Shokrian, N.
    Piontkowski, A.
    Ungar, B.
    Guttman-Yassky, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S162 - S162
  • [29] Real-World Experience and Laboratory Monitoring of Dupilumab in Patients with Moderate to Severe Atopic Dermatitis in a Tertiary Centre
    Kreeshan, Firas Constantin
    Al-Janabi, Ali
    Warren, Richard Bruce
    Hunter, Hamish John Alexander
    DERMATOLOGY AND THERAPY, 2021, 11 (01) : 149 - 160
  • [30] Real-world effectiveness and safety of dupilumab in managing children and adolescents with moderate-to-severe atopic dermatitis
    Marshall, Claire
    Littlewood, Zoe
    Herety, Nichola
    Heal, Calvin
    Sharif, Jennifer
    Clayton, Tim
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 196 - 196
12345